Logo image of CLF

CLEVELAND-CLIFFS INC (CLF) Stock Fundamental Analysis

NYSE:CLF - New York Stock Exchange, Inc. - US1858991011 - Common Stock - Currency: USD

10.49  +0.24 (+2.34%)

After market: 10.5499 +0.06 (+0.57%)

Fundamental Rating

3

Overall CLF gets a fundamental rating of 3 out of 10. We evaluated CLF against 152 industry peers in the Metals & Mining industry. CLF may be in some trouble as it scores bad on both profitability and health. CLF has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CLF had negative earnings in the past year.
In the past year CLF had a positive cash flow from operations.
CLF had positive earnings in 4 of the past 5 years.
Of the past 5 years CLF 4 years had a positive operating cash flow.
CLF Yearly Net Income VS EBIT VS OCF VS FCFCLF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B

1.2 Ratios

The Return On Assets of CLF (-2.75%) is comparable to the rest of the industry.
With a Return On Equity value of -6.74%, CLF is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.75%
ROE -6.74%
ROIC N/A
ROA(3y)8.38%
ROA(5y)6.55%
ROE(3y)25.54%
ROE(5y)30.81%
ROIC(3y)N/A
ROIC(5y)N/A
CLF Yearly ROA, ROE, ROICCLF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200

1.3 Margins

In the last couple of years the Profit Margin of CLF has declined.
In the last couple of years the Operating Margin of CLF has declined.
The Gross Margin of CLF (2.56%) is worse than 66.21% of its industry peers.
CLF's Gross Margin has declined in the last couple of years.
CLF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.56%
OM growth 3Y1.85%
OM growth 5Y-34.79%
PM growth 3YN/A
PM growth 5Y-48.14%
GM growth 3Y-10.8%
GM growth 5Y-28.89%
CLF Yearly Profit, Operating, Gross MarginsCLF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

3

2. Health

2.1 Basic Checks

CLF does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLF has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLF has more shares outstanding
The debt/assets ratio for CLF has been reduced compared to a year ago.
CLF Yearly Shares OutstandingCLF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
CLF Yearly Total Debt VS Total AssetsCLF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.80, we must say that CLF is in the distress zone and has some risk of bankruptcy.
CLF has a worse Altman-Z score (1.80) than 61.38% of its industry peers.
CLF has a debt to FCF ratio of 6.57. This is a slightly negative value and a sign of low solvency as CLF would need 6.57 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.57, CLF is in the better half of the industry, outperforming 64.83% of the companies in the same industry.
A Debt/Equity ratio of 0.55 indicates that CLF is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.55, CLF is doing worse than 80.69% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 6.57
Altman-Z 1.8
ROIC/WACCN/A
WACC10.5%
CLF Yearly LT Debt VS Equity VS FCFCLF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B

2.3 Liquidity

CLF has a Current Ratio of 1.85. This is a normal value and indicates that CLF is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.85, CLF is in line with its industry, outperforming 42.07% of the companies in the same industry.
A Quick Ratio of 0.55 indicates that CLF may have some problems paying its short term obligations.
CLF has a worse Quick ratio (0.55) than 88.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 0.55
CLF Yearly Current Assets VS Current LiabilitesCLF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

3

3. Growth

3.1 Past

CLF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -158.21%.
The earnings per share for CLF have been decreasing by -19.03% on average. This is quite bad
Looking at the last year, CLF shows a decrease in Revenue. The Revenue has decreased by -8.92% in the last year.
CLF shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 56.65% yearly.
EPS 1Y (TTM)-158.21%
EPS 3YN/A
EPS 5Y-19.03%
EPS Q2Q%-200%
Revenue 1Y (TTM)-8.92%
Revenue growth 3Y60.16%
Revenue growth 5Y56.65%
Sales Q2Q%-18.48%

3.2 Future

Based on estimates for the next years, CLF will show a small growth in Earnings Per Share. The EPS will grow by 2.34% on average per year.
Based on estimates for the next years, CLF will show a decrease in Revenue. The Revenue will decrease by -0.78% on average per year.
EPS Next Y-170.41%
EPS Next 2Y-58.07%
EPS Next 3Y2.34%
EPS Next 5YN/A
Revenue Next Year-12.01%
Revenue Next 2Y-3.79%
Revenue Next 3Y-0.64%
Revenue Next 5Y-0.78%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLF Yearly Revenue VS EstimatesCLF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B 20B
CLF Yearly EPS VS EstimatesCLF Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 4

3

4. Valuation

4.1 Price/Earnings Ratio

CLF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CLF is valuated quite expensively with a Price/Forward Earnings ratio of 57.94.
60.00% of the companies in the same industry are cheaper than CLF, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 93.88. CLF is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 57.94
CLF Price Earnings VS Forward Price EarningsCLF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLF indicates a somewhat cheap valuation: CLF is cheaper than 62.07% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CLF is valued cheaper than 91.72% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.03
EV/EBITDA 10.11
CLF Per share dataCLF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-58.07%
EPS Next 3Y2.34%

0

5. Dividend

5.1 Amount

CLF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEVELAND-CLIFFS INC

NYSE:CLF (1/30/2025, 8:14:59 PM)

After market: 10.5499 +0.06 (+0.57%)

10.49

+0.24 (+2.34%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-07 2025-02-07/amc
Inst Owners73.94%
Inst Owner Change-7.98%
Ins Owners1.63%
Ins Owner Change-1.39%
Market Cap5.18B
Analysts66.67
Price Target14.29 (36.22%)
Short Float %8.71%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)-44.93%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.54%
Min EPS beat(2)-90.92%
Max EPS beat(2)100%
EPS beat(4)2
Avg EPS beat(4)2.72%
Min EPS beat(4)-90.92%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)4.32%
EPS beat(12)5
Avg EPS beat(12)-3.61%
EPS beat(16)6
Avg EPS beat(16)-11.84%
Revenue beat(2)0
Avg Revenue beat(2)-4.13%
Min Revenue beat(2)-5.15%
Max Revenue beat(2)-3.12%
Revenue beat(4)0
Avg Revenue beat(4)-3.34%
Min Revenue beat(4)-5.15%
Max Revenue beat(4)-1.41%
Revenue beat(8)2
Avg Revenue beat(8)-1.85%
Revenue beat(12)4
Avg Revenue beat(12)-1.3%
Revenue beat(16)5
Avg Revenue beat(16)-1.27%
PT rev (1m)-1.07%
PT rev (3m)-4.08%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-462.02%
EPS NY rev (1m)0%
EPS NY rev (3m)-492.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.71%
Revenue NY rev (1m)-0.96%
Revenue NY rev (3m)-3.64%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 57.94
P/S 0.26
P/FCF 9.03
P/OCF 4.22
P/B 0.76
P/tB 0.92
EV/EBITDA 10.11
EPS(TTM)-0.39
EYN/A
EPS(NY)0.18
Fwd EY1.73%
FCF(TTM)1.16
FCFY11.08%
OCF(TTM)2.49
OCFY23.72%
SpS40.43
BVpS13.88
TBVpS11.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.75%
ROE -6.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.56%
FCFM 2.87%
ROA(3y)8.38%
ROA(5y)6.55%
ROE(3y)25.54%
ROE(5y)30.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.76%
ROCE(5y)11.93%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.85%
OM growth 5Y-34.79%
PM growth 3YN/A
PM growth 5Y-48.14%
GM growth 3Y-10.8%
GM growth 5Y-28.89%
F-Score3
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 6.57
Debt/EBITDA 4.34
Cap/Depr 70.58%
Cap/Sales 3.28%
Interest Coverage N/A
Cash Conversion 141.26%
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 0.55
Altman-Z 1.8
F-Score3
WACC10.5%
ROIC/WACCN/A
Cap/Depr(3y)78.73%
Cap/Depr(5y)231.51%
Cap/Sales(3y)3.5%
Cap/Sales(5y)10.48%
Profit Quality(3y)195.58%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-158.21%
EPS 3YN/A
EPS 5Y-19.03%
EPS Q2Q%-200%
EPS Next Y-170.41%
EPS Next 2Y-58.07%
EPS Next 3Y2.34%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.92%
Revenue growth 3Y60.16%
Revenue growth 5Y56.65%
Sales Q2Q%-18.48%
Revenue Next Year-12.01%
Revenue Next 2Y-3.79%
Revenue Next 3Y-0.64%
Revenue Next 5Y-0.78%
EBIT growth 1Y-109.68%
EBIT growth 3Y63.13%
EBIT growth 5Y2.16%
EBIT Next Year10.82%
EBIT Next 3Y32.74%
EBIT Next 5Y21.51%
FCF growth 1Y-72.96%
FCF growth 3YN/A
FCF growth 5Y41.39%
OCF growth 1Y-59.98%
OCF growth 3YN/A
OCF growth 5Y35.54%